Is Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA's patent grant rate increasing or decreasing?

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA's recent grant velocity is -78% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA

Q: Where does Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA ranks #25,349 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Technechnophage ranks #25,349 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#25,349
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.8/100): 25.3
avg claims per patent: -78%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25349 · Foreign Corporation #25,349 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,349/49,997
PHOTO-FINISH Tanya Taylor Designs
CPC-NARROW A61P · 8 areas
INNOV-THIN 35.8/100
CLAIMS-DENSE 25.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -78% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tanya Taylor Designs LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Technechnophage’s 35.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (24%) Velocity 2.2 pts (6%) Breadth 10.0 pts (28%) Claim depth 15.0 pts (42%)

Qualcomm Incorporated · highest

85
Technechnophage… · this assignee

36
3D Lighting… · lowest

7

What this shows Technechnophage's Innovation Score is 35.8/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Technechnophage?

Each dot is one of Technechnophage’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Technechnophage’s own 25.3 claims/patent is ABOVE the 7.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Technechnophage vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Technechnophage's grants concentrate

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA is a focused PatentsView assignee: 8 CPC subclasses with 81.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2020. By volume, Technechnophage sits between Tanya Taylor Designs LLC and Tecnica Group S.P.A..

Technechnophage's three-year grant acceleration

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tanya Taylor Desi…

11
Tate Access Floors

11
TAU Medical

11
Taylor Precision…

11
Technocrats

11
Humanware

11
' Xanadu OF Reson…

11
Tecnica Group S P…

11
Technechnophage I… ◀

11

What this shows Technechnophage holds 11 patents at rank #25,331, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Technechnophage

By rank, the assignees closest to #25,331 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Technechnophage's primary technology class.

Technechnophage's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	3	27.3%
2017	2	18.2%
2019	2	18.2%
2020	1	9.1%
2023	1	9.1%

Which technologies does Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C07K - Peptides 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA's patent record in context - here's where to go next.

Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 81.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #25,349 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Technechnophage, Investigacao E Desenvolvimento EM Biotecnologia, SA against Tanya Taylor Designs LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.